FY22 results deliver sustainable growth
For the year to 30 September 2022, Benchmark Holdings reported revenue of £158.3m, +27%YoY and...
Read more
Validation for microbiomes
With the first ever FDA approval for a faecal microbiome drug the door has been opened for other...
Read more
Trading update / Completion of Billi acquisition
Ongoing lockdowns in South China have impacted two of the Group’s largest OEM customers during the...
Read moreSolid H1 amidst weakening macro environment
LendInvest continued to grow and gain market share in H1 of FY23 (to 30 Sep 22), with AUM closing...
Read more
Revenue, profit, cash & dividends up materially
Given the sharp pullback in financial markets, which saw growth stocks and ‘sustainable’ stocks in...
Read more
The strong get stronger
Today the company posted a “solid” set of H1’23 results, that was also in line with our FY’23...
Read moreH1'23 results buoyed by strong performance from Vaping
For the six months to 30 September, Supreme reported revenue growth of 6%YoY to £64.6m, EBITDA...
Read more
Register to be first
Get research on the companies that interest you straight to your inbox
